| 标题 |
[高分]
ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer: final overall survival (OS) analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Journal of Gynecological Cancer 作者:Andrew Clamp; Iain Mcneish; Domenico Radice; Rosemary Lord; Agnieszka Michael; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)